Hypoperfusion is the main risk factor for the development of non-tuberculous mycobacterial lung disease in CTEPH

M. Szturmowicz, K. Oniszh, E. Wilinska, A. Kacprzak, E. Augustynowicz-Kopec, M. Kurzyna, M. Wieteska, A. Torbicki, J. Kus (Warsaw, Otwock, Poland)

Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers
Session: Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers
Session type: Thematic Poster Session
Number: 2605
Disease area: Pulmonary vascular diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Szturmowicz, K. Oniszh, E. Wilinska, A. Kacprzak, E. Augustynowicz-Kopec, M. Kurzyna, M. Wieteska, A. Torbicki, J. Kus (Warsaw, Otwock, Poland). Hypoperfusion is the main risk factor for the development of non-tuberculous mycobacterial lung disease in CTEPH. Eur Respir J 2013; 42: Suppl. 57, 2605

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Thrombophilic risk factors for chronic thromboembolic pulmonary hypertension (CTEPH) in Korea
Source: International Congress 2015 – Pulmonary circulation: pulmonary embolism and chronic thromboembolic pulmonary hypertension
Year: 2015

Chronic thromboembolic pulmonary hypertension and idiopathic pulmonary hypertension are the conditions predisposing to non-tuberculous mycobacterial lung disease (NTMLD)
Source: Annual Congress 2011 - Clinical characteristics of patients with pulmonary hypertension
Year: 2011


Risk factors of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism
Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension
Year: 2014

The incidence of chronic thromboembolic pulmonary hypertension in asympthomatic pulmonary embolism patients
Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension
Year: 2014

HbA1c-levels in patients with operable chronic thromboembolic pulmonary hypertension
Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension
Year: 2014


Pulmonary hypertension due to lung disease
Source: International Congress 2017 – Russian Programme 2017
Year: 2017

Pulmonary embolism is more prevalent than deep vein thrombosis in cases of chronic obstructive pulmonary disease and interstitial lung diseases
Source: International Congress 2016 – Acute pulmonary embolism
Year: 2016

Risk of nontuberculous mycobacterial pulmonary disease with obstructive lung disease
Source: Eur Respir J 2016; 48: 928-931
Year: 2016


Incidence and outcomes of haemoptysis in patients with operable and non-operable chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH)
Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension
Year: 2016


Hemodynamic assessment of patients with pulmonary hypertension due to lung disease and/or hypoxia
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II
Year: 2013

Prevalence of relapses and chronic thromboembolic pulmonary hypertension (CTEPH) in patients with pulmonary embolism (PE)
Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology
Year: 2016


Pulmonary hypertension correction in patients with chronic obstructive pulmonary disease and essential hypertension
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014


Pulmonary artery dissection (PAD) in a patient with diffuse interstitial lung disease and chronic thromboembolic pulmonary hypertension (CTEPH)
Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside
Year: 2016


Clinical and prognostic scores in patients with cancer and pulmonary embolism
Source: International Congress 2016 – Acute pulmonary embolism
Year: 2016

Pulmonary embolism in COPD patients
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013

Mitomycin-induced pulmonary veno-occlusive disease: Experience from the French pulmonary hypertension network
Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH
Year: 2015


Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease
Source: Eur Respir J 2011; 39: 125-132
Year: 2012



Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease
Source: Eur Respir J 2012; 39: 125-132
Year: 2012



Risk factors for chronic thromboembolic pulmonary hypertension
Source: Eur Respir J 2009; 33: 325-331
Year: 2009



The incidence of chronic thromboembolic pulmonary hypertension secondary to acute pulmonary thromboembolism
Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension
Year: 2014